Calcium nke rosuvastatin

Nkọwa dị mkpirikpi:

Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP
Calcium nke rosuvastatin Hypercholesterolemia N'ime ụlọ/CEP 20705 CEP2015-240


Nkọwa ngwaahịa

Mkpado ngwaahịa

Nkọwa ngwaahịa

瑞舒伐他汀钙 Calcium nke rosuvastatin 147098-20-2 N'ime ụlọ/CEP
kristal (RSM) 147118-40-9 N'ime ụlọ
RSM( Crude) 147118-40-9 N'ime ụlọ
RSP - N'ime ụlọ
RS-8 147118-36-3 N'ime ụlọ
RS-8-1 147118-37-4 N'ime ụlọ
TP-8 131466-61-0 N'ime ụlọ
TP-11 147118-35-2 N'ime ụlọ
TP-13 147118-39-6 N'ime ụlọ
RS-10 289042-12-2 N'ime ụlọ
RS-11 355806-00-7 N'ime ụlọ

Nkọwa

A na-akpọ Calcium Rosuvastatin (BANM, JAN, USAN) dị ka Rosuvastatin na US.na ihe mgbochi HMG-CoA reductase inhibitor nwere IC50 nke 11 nM[1].Calcium Rosuvastatin na-egbochi mkpụrụ ndụ ihe nketa ether-a-go-go mmadụ (hERG) dị ugbu a yana IC50 nke 195 nM, na-egbu oge nkwughachi obi, wee si otú a mee ogologo oge ọrụ nwere ike ime (APDs) wee mezie nkeji oge QT (QTc).Calcium Rosuvastatin na-ebelata ngosipụta nke hERG tozuru oke yana mmekọrịta nke protein ujo 70 (Hsp70) na protein hERG.Calcium Rosuvastatin na-arụ ọrụ nke ọma n'ibelata lipoprotein dị obere (LDL), triglycerides na protein C-reactive [3].

Ozi ndị ọzọ gbasara mgbakọ n'ịkpọ aha ọgwụ: International Nonproprietary Names.

Ọkwa dị mkpa: Drugs.com nchekwa data mba ụwa dị na ntọhapụ BETA.Nke a pụtara na ọ ka na-etolite ma nwee ike ịnwe ezighi ezi.Ebubeghi ya ka ọ nọchiri anya nka na ikpe nke dibịa gị, onye na-ere ọgwụ ma ọ bụ ọkachamara ahụike ọzọ.E kwesịghị ịkọwa ya iji gosi na iji ọgwụ ọ bụla na obodo ọ bụla dị mma, dabara ma ọ bụ dị irè maka gị.Kpọtụrụ ọkachamara ahụike gị tupu ị were ọgwụ ọ bụla.

Na US, Rosuvastatin (rosuvastatin systemic) bụ onye so na klas ọgwụ statins ma na-eji agwọ Atherosclerosis, Cholesterol dị elu, Cholesterol dị elu - Ezinụlọ Heterozygous, Cholesterol dị elu - Familial Homozygous, Hyperlipoproteinemia, Hyperlipoproteinemia Ụdị IIa - elu LDL, Hyperlipoproteinemia Type IIa - elu LDL, hyperlipoproteinemia. IIb - LDL VLDL dị elu, Hyperlipoproteinemia Ụdị III - Beta-VLDL IDL dị elu, Hyperlipoproteinemia Ụdị IV - VLDL dị elu, Hypertriglyceridemia na Mgbochi Ọrịa obi.

ndabere

Nhọrọ, onye na-egbochi asọmpi nke HMG-CoA reductase, nke ahụ bụkwa antilipemic.

 

Nchekwa

Ntụ ntụ

-20°C

Afọ 3

4°C

afọ 2
Na ihe mgbaze

-80 Celsius

Ọnwa isii

-20°C

1 ọnwa

Ọdịdị chemical

Rosuvastatin Calcium

Asambodo

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

njikwa mma

Quality management1

Atụmatụ18Ọrụ nlebanya na-agbanwe agbanwe nke akwadoro4, na6A na-akwado ọrụ ngo.

Quality management2

Usoro njikwa ogo mba ụwa dị elu etinyela ntọala siri ike maka ire ahịa.

Quality management3

Nlekọta dị mma na-aga n'ihu na usoro ndụ nke ngwaahịa ahụ niile iji hụ na ịdịmma na mmetụta ọgwụgwọ.

Quality management4

Ndị otu Regulatory Affairs ndị ọkachamara na-akwado ịdịmma chọrọ n'oge ngwa na ndebanye aha.

njikwa mmepụta

cpf5
cpf6

Ahịrị nkwakọ ngwaahịa Korea Countec

cpf7
cpf8

Taiwan CVC ahịrị nkwakọ ngwaahịa

cpf9
cpf10

Line CAM Board Ịtali

cpf11

Igwe na-akpakọrịta Fette German

cpf12

Ihe nchọpụta mbadamba ihe ngosi nke Japan

cpf14-1

Ụlọ njikwa DCS

Onye mmekọ

Mmekọrịta mba ụwa
International cooperation
Imekọ ihe ọnụ n'ụlọ
Domestic cooperation

  • Nke gara aga:
  • Osote:

  • Dee ozi gị ebe a ziga anyị ya

    Ụdị ngwaahịa